Summary

Overview
The global automated ophthalmic perimeters market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
Automated ophthalmic perimeter is an ocular device used to measure the eye's visual field and diagnose numerous eye conditions such as glaucoma, cataracts, and dry eyes. The ophthalmic perimeter helps evaluate the visual field by using different corners & intensities to measure the sensitivity. In addition, the device detects pathological modifications in the visual field of a person.
The ophthalmic perimeters medical devices can also help in the detection of any visual disorders in humans by testing the sensitivity of light. The ophthalmic perimeters are also used to detect pathological modifications and their application extends to diagnosis of the eye disease, evaluation of visual skills, classification of disability, and distinct kinds of eye testing exams.
A perimeter is an ophthalmic device that detects any central and peripheral vision issues. While using the perimeter, stimulus (light) of different sizes, shapes, and intensities is presented to patients looking into the device. The device automatically records the reading of the patient response and gives the visual field results.
Market Dynamics: Drivers
Technological advancements in the perimeters coupled with the growing number of ophthalmic disease conditions
An increase in technological advancements in the perimeters such as high-quality displays, simplifying operating procedures, and development of image processing & software for analysis are driving the growth of the ophthalmic perimeters market.
Furthermore, the growing number of ophthalmic disease conditions such as glaucoma in all age groups especially in old age, and the increasing number of geriatric populations is boosting the growth of the automated ophthalmic perimeters market.
The aging of the population is projected to lead to the prevalence of glaucoma among adults 40 to 80 years old to rise promptly from 76 million in 2020 to 111.8 million in 2040. For instance, an October 2023, NCBI study stated that over 80 million people globally suffer from glaucoma.
Moreover, growing demand for accurate results in less time, and due to the high resolution provided by an ophthalmic perimeter, it is easy to capture a wide affected area in a minimum time. Thus, the availability of combined instruments in the market helps to analyze peripheral defects. All these factors are boosting the demand for automated ophthalmic perimeters market.
The high prevalence of ophthalmic diseases is anticipated to drive the automated ophthalmic perimeters Market over the forecast period. As per the WHO update in August 2023, the global near- or farsightedness population is at least 2.2 billion individuals.
In a minimum of 1 billion of these cases, vision impairment may have been prevented or remains untreated. Refractive errors and cataracts are the two most prevalent causes of vision impairment and blindness in the globe.
Restraints
Factors such as high cost associated with ophthalmic products, lack of skilled people and ophthalmologists, and lack of access in underdeveloped countries.
Generally, automated perimeters are markedly more expensive than manual devices, require mechanical servicing, and therefore may have considerable periods of downtime. A significant number of patients do not test well with automated devices but perform well with manual techniques is expected to hamper the market.
For more details on this report - Request for Sample
Segment Analysis
The automated ophthalmic perimeters market is segmented based on application, product, end-user, and region.
The static segment accounted for approximately 54.4% of the automated ophthalmic perimeters market share
The static segment is expected to hold the largest market share over the forecast period. The static perimeter is the most preferred method for assessing visual field quality, detecting glaucoma, and monitoring glaucoma-related changes in the visual field. The outcomes of this exam are strongly influenced by the test taker.
For that reason, it is usually done twice, and often three times, in a single session. Furthermore, the effective use of the static perimeter for visual field testing in glaucoma-affected children is expected to stimulate the growth of the segment.
The rise in demand for advanced early diagnostic techniques, favorable reimbursement scenarios for ophthalmic disease diagnosis & treatment, and a surge in lifestyle & age-associated ophthalmic diseases such as glaucoma and cataracts are the significant factors that drive the growth of the segment.
In addition, an increase in the number of ophthalmic perimeter manufacturers, a high adoption rate for advanced ophthalmic perimeter technologies, and practical usage of the static ophthalmic perimeter for visual field testing in children with glaucoma augment the segment's growth.
In static perimetry, stationary stimuli are presented at defined points in the visual field. Stimuli presented for longer durations of time may be seen better as a result of temporal summation of information, though limited additional benefit is derived beyond times over 1/10th of a second.
Visual function assessment is integral to the evaluation and management of glaucoma. Visual field testing can be performed by various methods, including confrontation technique, Amsler grid, tangent screen, kinetic perimetry, or static perimetry. This focus is primarily on standard automated perimetry (SAP). Advances in computer technology have facilitated more sensitive and reproducible visual field loss detection than was possible with manual perimetry, allowing clinicians to detect glaucoma earlier in its course and to monitor loss quantitatively over time.
The Humphrey and Octopus perimeters use stimuli presented for 0.2 seconds and 0.1 seconds, respectively, maximizing temporal summation while minimizing patient attempts to redirect fixation towards the stimulus. In static automated ophthalmic perimetry, stationary stimuli are presented at defined points in the visual field.
Technological advancements in the industry are expected to drive the static automated ophthalmic perimeters segment over the forecast period. Technological advancements have increased accuracy in visual field testing and reduced turnaround time. The use of new software algorithms in static automated ophthalmic perimeters is one of the major technological advances in the industry.
Geographical Analysis
North America accounted for approximately 41.3% of the automated ophthalmic perimeters market share
North America region is expected to hold the largest market share over the forecast period. This is because there are numerous market participants in the area as well as a rise in the incidence of eye disorders. The market for automated visual field analyzers is being driven by favorable reimbursement policies and the high adoption of the newest technology.
In the U.S., as per CDC statistics in August 2023, 6.1 million (5.1%) have had their lenses surgically removed, while an estimated 20.5 million (17.2%) who are 40 years of age and older have cataracts in one or both of their eyes. By 2022, there will likely be 30.1 million cataract sufferers worldwide.
Major mergers and acquisitions among key healthcare players, driven to introduce innovations and better patient experience are significant market trends. in May 2023, Astellas Pharma Inc. acquired Iveric Bio Inc., this business is well-known for its proficiency in eye treatments research and development. To address the growing effects of vision loss, governments have increased efforts to improve access to eye care services as part of universal health coverage in partnership with the UN.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the automated ophthalmic perimeters market. The World Health Organization (WHO), on January 30, 2020, declared the COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe.
The implementation of the lockdown due to the COVID-19 attack has delayed the treatment for ophthalmic disorders up to six months to one year, thereby having a minimal negative impact on the market. Owing to the COVID-19 pandemic, many hospitals across the globe were restructured to increase the hospital capacity for patients diagnosed with COVID-19.
This led to the cancellation of many primary investigations and unnecessary surgical procedures for eye diseases such as cataracts and glaucoma. Thus, the COVID-19 pandemic is likely to harm the growth of the overall automated ophthalmic perimeter market.
According to an article published by PubMed in 2021, the inappropriate wearing of face masks can cause visual field artifacts, which may be interpreted as low-test reliability or glaucoma progression.
Ophthalmologists across the globe were reporting many indications of eye infection. This data was further used to help the professionals understand the possible symptoms and the stage of this viral disease when the eye infections probably occur.
Various literature searches were conducted for ophthalmic manifestation of Covid-19 during 2020 and early 2021. These kinds of literature include 46 case reports, 8 case series, 11 observational studies, 5 interventional studies, 3 animal models’ studies, and 6 meta-analyses.
Market Segmentation
By Application
- Glaucoma
- Dry Eye
- Cataract
By Product
- Static
- Kinetic
- Combination
By End-Users
- Hospitals
- Ophthalmic Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Competitive Landscape
The major global players in the automated ophthalmic perimeters market include Carl Zeiss AG, Heidelberg Engineering GmbH, Konan Medical USA, Inc., Topcon Corporation, Centerview S.P.A., Optopol Technology Sp. z o.o, Nidek Co., Ltd, Haag-Streit AG, Takagi Seiko Co., Ltd and Medmont among others.
Key Developments
- On January 6, 2023, Pune (India) based Jehangir Hospital enhanced the scope of its Ophthalmology Department with the launch of the latest Ophthalmology Centre.
- On October 27, 2022, ZEISS Medical Technology announced a strategic partnership with the European Association of Neurosurgical Societies (EANS).
- On October 12, 2022, The ZEISS Semiconductor Manufacturing Technology (SMT) sector is expanding its SMT facility in Dillfeld, Wetzlar, to meet the high level of client demand. Also, ZEISS Medical Technology announced that it had received 510(k) clearance from the FDA for MTLawtonTM. These new disposable bipolar forceps are made from a special copper-base alloy and potentially reduce tissue adhesion and subsequent charring during tissue dissection. Thanks to the extended shaft, the forceps also reduce visual restrictions in the surgical field and help surgeons to be efficient during electrosurgical procedures.
- On May 16, 2022, Takagi Seiko, a manufacturer of eye care devices launched the 2ZL BG Lamp microscope and Flat Base for OM-6. It is considered to be an important element of medical services as it provides an explanation of the conditions besides capturing the image.
- On July 13, 2021, ZEISS introduced a fully integrated ecosystem where a combination of data management, devices, services, and applications will drive continuous improvement of patient outcomes. It would expand integrated workflow solutions at ZEISS.
Why Purchase the Report?
- To visualize the automated ophthalmic perimeters market segmentation based on application, product, end-user, and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of automated ophthalmic perimeters market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping is available in excel consisting of key products of all the major players.
The automated ophthalmic perimeters market report would provide approximately 62 tables, 53 figures, and 183 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Application
3.2. Snippet by Product
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological Advancements in the Perimeters Coupled with the Growing Number of Ophthalmic Disease Conditions
4.1.2. Restraints
4.1.2.1. High-Cost Associates with the Ophthalmic Products
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Glaucoma*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Dry Eye
7.4. Cataract
7.5. Others
8. By Product
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
8.1.2. Market Attractiveness Index, By Product
8.2. Static *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Kinetic
8.4. Combination
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ophthalmic Clinics
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. South Korea
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Konan Medical USA, Inc *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Carl Zeiss AG
12.3. Heidelberg Engineering GmbH
12.4. Topcon Corporation
12.5. Centervue S.P.A
12.6. Optopol Technology Sp. z o.o
12.7. Nidek Co., Ltd
12.8. Haag-Streit AG
12.9. Takagi Seiko Co., Ltd
12.10. Medmont
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us